Media ReleasesOventus Medical

View All Oventus Medical News


Oventus Medical, Appendix 4C - quarterly


Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is pleased to announce its Appendix 4C and quarterly business activities review for the three-month period ended 31 March 2020 (Q3 FY2020).

For more information, download the attached PDF. 
Download this document